1. Peters WP, Eder JP, Henner WD, Bast RC Jr, Schnipper L, Frei E III: Novel toxicities associated with high-dose combination alkylating agents and autologous bone marrow support.In: Dicke C, Spitzer G, Zander A (eds) Autologous Bone Marrow Transplantation: Proceedings of the First International Symposium. Houston, University of Texas MD Anderson Hospital and Tumor Institute, 1985, pp 231-236
2. Jones RB, Matthes S: Pharmacokinetics.In: Armitage JO, Antman KH (eds) High-Dose Cancer Therapy: Pharmacology, Hematopoietins, and Stem Cells. Williams and Wilkins, Baltimore, 1992, pp 43?60
3. Jones RB, Shpall EJ, Ross M, Coniglio D, Affronti ML, Peters WP: High-dose carboplatin, cyclophosphamide, and BCNU with autologous bone marrow support: excessive hepatic toxicity. Cancer Chemother Pharmacol 26:155?156, 1990
4. Ayash LS, Wright JE, Tretyakov O, Gonin R, Elisa A, Wheeler C, Eder JP, Rowosky A, Antman K, Frei E: Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and antitumor response. J Clin Oncol 10:995?1000, 1992
5. Jones RB, Matthes SM, Shpall EJ, Stemmer S, Bearman SI: Acute lung injury following high-dose cyclophosphamide, cisplatin, and BCNU: pharmacodynamic evaluation of BCNU. J Natl Cancer Inst (in press)